Evolent Health Announces Second Quarter 2022 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Wall Street sinks as Nasdaq falls over 2% on AI cost worries
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
Evolent Health (EVH) Tops Q2 EPS by 5c, Rases Guidance
August 2, 2022 4:31 PM EDTEvolent Health (NYSE: EVH) reported Q2 EPS of $0.10, $0.05 better than the analyst estimate of $0.05. Revenue for the quarter came in at $319.9 million versus the consensus estimate of $298.79 million.
GUIDANCE:
Evolent Health sees FY2022 revenue of $1.32-1.36 billion, versus the consensus of... More



